Prostate cancer is the most common cancer affecting American men other than skin cancer and the second leading cause of male ...

ASCO 2025 will showcase cutting-edge advancements in precision medicine, artificial intelligence, and biomarker-driven ...

Discover a recent study that has identified a gene that plays a role in prostate cancer susceptibility. Learn more.

As part of a $93 million grant package, the Cancer Prevention and Research Institute of Texas, known for funding ...

Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker-based study (Alliance A032102). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...

The FDA's ODAC voted unanimously against the risk-benefit profile of talazoparib and enzalutamide for the treatment of mCRPC ...

At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage ...

Northwestern Medicine investigators have discovered that a novel long noncoding RNA (lncRNA), which are usually 200 ...

While there’s no such thing as a prostate cancer diet, some nutrition choices are better than others if you are managing the disease. Try these tips to choose the best foods, and learn the ...

Plus: Trump’s Surgeon General nominee and MAHA; and what Israeli officials are privately saying about starvation in Gaza.